179 related articles for article (PubMed ID: 35233740)
21. Pediatric patients with pheochromocytoma and paraganglioma should have routine preoperative genetic testing for common susceptibility genes in addition to imaging to detect extra-adrenal and metastatic tumors.
Babic B; Patel D; Aufforth R; Assadipour Y; Sadowski SM; Quezado M; Nilubol N; Prodanov T; Pacak K; Kebebew E
Surgery; 2017 Jan; 161(1):220-227. PubMed ID: 27865588
[TBL] [Abstract][Full Text] [Related]
22. An update on the genetics of paraganglioma, pheochromocytoma, and associated hereditary syndromes.
Gimenez-Roqueplo AP; Dahia PL; Robledo M
Horm Metab Res; 2012 May; 44(5):328-33. PubMed ID: 22328163
[TBL] [Abstract][Full Text] [Related]
23. ATRX driver mutation in a composite malignant pheochromocytoma.
Comino-Méndez I; Tejera ÁM; Currás-Freixes M; Remacha L; Gonzalvo P; Tonda R; Letón R; Blasco MA; Robledo M; Cascón A
Cancer Genet; 2016 Jun; 209(6):272-7. PubMed ID: 27209355
[TBL] [Abstract][Full Text] [Related]
24. Genetics of pheochromocytoma and paraganglioma.
Wachtel H; Fishbein L
Curr Opin Endocrinol Diabetes Obes; 2021 Jun; 28(3):283-290. PubMed ID: 33764930
[TBL] [Abstract][Full Text] [Related]
25. Discriminating pheochromocytomas from other adrenal lesions: the dilemma of elevated catecholamines.
Carr JC; Spanheimer PM; Rajput M; Dahdaleh FS; Lal G; Weigel RJ; Sugg SL; Liao J; Howe JR
Ann Surg Oncol; 2013 Nov; 20(12):3855-61. PubMed ID: 23884753
[TBL] [Abstract][Full Text] [Related]
26. Malignant pheochromocytomas and paragangliomas: a diagnostic challenge.
Gimm O; DeMicco C; Perren A; Giammarile F; Walz MK; Brunaud L
Langenbecks Arch Surg; 2012 Feb; 397(2):155-77. PubMed ID: 22124609
[TBL] [Abstract][Full Text] [Related]
27. The occurrence of SDHB gene mutations in pheochromocytoma.
Van Nederveen FH; Dinjens WN; Korpershoek E; De Krijger RR
Ann N Y Acad Sci; 2006 Aug; 1073():177-82. PubMed ID: 17102084
[TBL] [Abstract][Full Text] [Related]
28. H-RAS mutations are restricted to sporadic pheochromocytomas lacking specific clinical or pathological features: data from a multi-institutional series.
Oudijk L; de Krijger RR; Rapa I; Beuschlein F; de Cubas AA; Dei Tos AP; Dinjens WN; Korpershoek E; Mancikova V; Mannelli M; Papotti M; Vatrano S; Robledo M; Volante M
J Clin Endocrinol Metab; 2014 Jul; 99(7):E1376-80. PubMed ID: 24684458
[TBL] [Abstract][Full Text] [Related]
29. Prognostic indicators of malignancy in adrenal pheochromocytomas: clinical, histopathologic, and cell cycle/apoptosis gene expression analysis.
Strong VE; Kennedy T; Al-Ahmadie H; Tang L; Coleman J; Fong Y; Brennan M; Ghossein RA
Surgery; 2008 Jun; 143(6):759-68. PubMed ID: 18549892
[TBL] [Abstract][Full Text] [Related]
30. Pheochromocytomas and Hypertension.
Pappachan JM; Tun NN; Arunagirinathan G; Sodi R; Hanna FWF
Curr Hypertens Rep; 2018 Jan; 20(1):3. PubMed ID: 29356966
[TBL] [Abstract][Full Text] [Related]
31. Pheochromocytoma: A three-decade clinical experience in a multicenter study.
Iglesias P; Santacruz E; García-Sancho P; Marengo AP; Guerrero-Pérez F; Pian H; Fajardo C; Villabona C; Díez JJ
Rev Clin Esp (Barc); 2021 Jan; 221(1):18-25. PubMed ID: 33998473
[TBL] [Abstract][Full Text] [Related]
32. The VHL/HIF Axis in the Development and Treatment of Pheochromocytoma/Paraganglioma.
Peng S; Zhang J; Tan X; Huang Y; Xu J; Silk N; Zhang D; Liu Q; Jiang J
Front Endocrinol (Lausanne); 2020; 11():586857. PubMed ID: 33329393
[TBL] [Abstract][Full Text] [Related]
33. Pheochromocytoma Characteristics and Behavior Differ Depending on Method of Discovery.
Gruber LM; Hartman RP; Thompson GB; McKenzie TJ; Lyden ML; Dy BM; Young WF; Bancos I
J Clin Endocrinol Metab; 2019 May; 104(5):1386-1393. PubMed ID: 30462226
[TBL] [Abstract][Full Text] [Related]
34. Exosomal double-stranded DNA as a biomarker for the diagnosis and preoperative assessment of pheochromocytoma and paraganglioma.
Wang L; Li Y; Guan X; Zhao J; Shen L; Liu J
Mol Cancer; 2018 Aug; 17(1):128. PubMed ID: 30139385
[TBL] [Abstract][Full Text] [Related]
35. Case report: Incidentally discovered case of pheochromocytoma as a cause of long COVID-19 syndrome.
Ziegler CG; Riediger C; Gruber M; Kunath C; Ullrich M; Pietzsch J; Nölting S; Siepmann T; Bornstein SR; Remde H; Constantinescu G
Front Endocrinol (Lausanne); 2022; 13():967995. PubMed ID: 36237184
[TBL] [Abstract][Full Text] [Related]
36. Genetics and clinical characteristics of hereditary pheochromocytomas and paragangliomas.
Welander J; Söderkvist P; Gimm O
Endocr Relat Cancer; 2011 Dec; 18(6):R253-76. PubMed ID: 22041710
[TBL] [Abstract][Full Text] [Related]
37. CT Texture Analysis of Adrenal Pheochromocytomas: A Pilot Study.
Crimì F; Agostini E; Toniolo A; Torresan F; Iacobone M; Tizianel I; Scaroni C; Quaia E; Campi C; Ceccato F
Curr Oncol; 2023 Feb; 30(2):2169-2177. PubMed ID: 36826128
[TBL] [Abstract][Full Text] [Related]
38. Semiquantitative 123I-Metaiodobenzylguanidine Scintigraphy to Distinguish Pheochromocytoma and Paraganglioma from Physiologic Adrenal Uptake and Its Correlation with Genotype-Dependent Expression of Catecholamine Transporters.
van Berkel A; Rao JU; Lenders JW; Pellegata NS; Kusters B; Piscaer I; Hermus AR; Plantinga TS; Langenhuijsen JF; Vriens D; Janssen MJ; Gotthardt M; Timmers HJ
J Nucl Med; 2015 Jun; 56(6):839-46. PubMed ID: 25883126
[TBL] [Abstract][Full Text] [Related]
39. How to detect pheochromocytomas?--the diagnostic relevance of plasma free metanephrines.
Roden M
Wien Klin Wochenschr; 2002 Apr; 114(7):246-51. PubMed ID: 12089859
[TBL] [Abstract][Full Text] [Related]
40. Diagnosis and management of pheochromocytoma: a practical guide to clinicians.
Pappachan JM; Raskauskiene D; Sriraman R; Edavalath M; Hanna FW
Curr Hypertens Rep; 2014 Jul; 16(7):442. PubMed ID: 24792093
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
